Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $6.51M.
ENTERPRISE VALUE (EV)
$6.51M
Actuate Therapeutics Inc
Market Cap
$19.26M
Enterprise Value (EV)
$6.51M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $19.26M | $6.51M |
| Cosmos Health Inc. (COSM)vs › | $19.02M | $33.19M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.87M | $18.72M |
| Dyadic International, Inc. (DYAI)vs › | $17.19M | $20.81M |
| Lipocine Inc. (LPCN)vs › | $17.07M | $12.09M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | $19.61M |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | $13.80M |
| BioCardia, Inc. (BCDA)vs › | $16.49M | $12.67M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | $21.06M |
| LeonaBio, Inc. (LONA)vs › | $22.80M | N/A |
Market Cap
$19.26M
Total Debt
$404991.00
Cash
$13.16M
Enterprise Value
$6.51M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
